"bnt162b2"

The move comes a day after rival Moderna said it was asking US and European regulators to allow emergency use of its COVID-19 vaccine.

The analysis was conducted on Sunday by an external, independent Data Monitoring Committee (DMC) from the Phase-3 clinical study.